Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EME-TIPAC
2014-004058-32Phase 3Completed
- Sponsor
- Norfolk and Norwich University Hospitals NHS Foundation Trust
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of trimethoprim + sulfamethoxazole in idiopathic pulmonary fibrosis (IPF) (2 arms), sponsored by Norfolk and Norwich University Hospitals NHS Foundation Trust. Primary endpoint: Time to death, lung transplant, or first non-elective hospital admission. Started Jun 2015; status: completed.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on 2014-004058-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004058-32.